Clinical trial
Ginseng as an Intervention to Decrease Cancer-Related Fatigue in Post-Treatment Cancer Survivors: A Randomized Controlled Pilot Study
NCT03407716 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ginseng as an Intervention to Decrease Cancer-Related Fatigue in Post-Treatment Cancer Survivors: A Randomized Controlled Pilot Study
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 1, 2019
- Completion date
- February 22, 2021
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer survivor, stage i breast cancer ajcc v7, stage i colon cancer ajcc v6 and v7, stage ia breast cancer ajcc v7, stage ib breast cancer ajcc v7, stage ii breast cancer ajcc v6 and v7, stage ii colon cancer ajcc v7, stage iia breast cancer ajcc v6 and v7, stage iia colon cancer ajcc v7, stage iib breast cancer ajcc v6 and v7, stage iib colon cancer ajcc v7, stage iic colon cancer ajcc v7, stage iii breast cancer ajcc v7, stage iii colon cancer ajcc v7, stage iiia breast cancer ajcc v7, stage iiia colon cancer ajcc v7, stage iiib breast cancer ajcc v7, stage iiib colon cancer ajcc v7, stage iiic breast cancer ajcc v7, stage iiic colon cancer ajcc v7